Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT
NCT07511127
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
218
Enrollment
OTHER
Sponsor class
Conditions
Hematologic Malignancy
Interventions
DRUG:
Maribavir
Sponsor
Ruijin Hospital